Published in J Biol Chem on November 24, 2000
Streptococcus adherence and colonization. Microbiol Mol Biol Rev (2009) 2.83
Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev (2005) 2.36
Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect Immun (2002) 2.15
Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect Immun (2001) 2.03
Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi. Infect Immun (2001) 2.02
Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface. Infect Immun (2004) 1.91
Intraclonal variations among Streptococcus pneumoniae isolates influence the likelihood of invasive disease in children. J Infect Dis (2013) 1.84
Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol (2010) 1.68
Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infect Immun (2001) 1.62
PavA of Streptococcus pneumoniae modulates adherence, invasion, and meningeal inflammation. Infect Immun (2005) 1.54
Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. Nat Rev Microbiol (2010) 1.52
Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway. Infect Immun (2008) 1.42
Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B. Infect Immun (2008) 1.33
The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect Immun (2002) 1.28
Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model. Infect Immun (2007) 1.25
Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1. Infect Immun (2002) 1.24
Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice. Infect Immun (2007) 1.22
Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens. Infect Immun (2010) 1.22
Pneumococcal surface protein C contributes to sepsis caused by Streptococcus pneumoniae in mice. Infect Immun (2004) 1.15
Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3. Infect Immun (2005) 1.14
The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15. Infect Immun (2002) 1.14
Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells. J Biol Chem (2010) 1.13
ZmpB, a novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis factor alpha production in the respiratory tract. Infect Immun (2003) 1.12
The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype. Infect Immun (2009) 1.11
Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation. Immunology (2006) 1.10
Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I. Infect Immun (2004) 1.10
Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children. Infect Immun (2002) 1.10
Role of complement in host defense against pneumococcal otitis media. Infect Immun (2009) 1.09
Species-specific interaction of Streptococcus pneumoniae with human complement factor H. J Immunol (2008) 1.08
PfbA, a novel plasmin- and fibronectin-binding protein of Streptococcus pneumoniae, contributes to fibronectin-dependent adhesion and antiphagocytosis. J Biol Chem (2008) 1.08
Recruitment of complement factor H-like protein 1 promotes intracellular invasion by group A streptococci. Infect Immun (2003) 1.06
Interaction of pneumococcal histidine triad proteins with human complement. Infect Immun (2010) 1.05
The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement. Infect Immun (2010) 1.05
Impact of the SpeB protease on binding of the complement regulatory proteins factor H and factor H-like protein 1 by Streptococcus pyogenes. Infect Immun (2005) 1.04
Human pathogenic Borrelia spielmanii sp. nov. resists complement-mediated killing by direct binding of immune regulators factor H and factor H-like protein 1. Infect Immun (2007) 1.04
The contribution of PspC to pneumococcal virulence varies between strains and is accomplished by both complement evasion and complement-independent mechanisms. Infect Immun (2006) 1.03
The choline-binding protein PspC of Streptococcus pneumoniae interacts with the C-terminal heparin-binding domain of vitronectin. J Biol Chem (2013) 1.01
Antibodies to pneumococcal proteins PhtD, CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriage. Clin Vaccine Immunol (2009) 0.99
The opportunistic human pathogenic fungus Aspergillus fumigatus evades the host complement system. Infect Immun (2007) 0.98
New adhesin functions of surface-exposed pneumococcal proteins. BMC Microbiol (2010) 0.95
Serotype-related variation in susceptibility to complement deposition and opsonophagocytosis among clinical isolates of Streptococcus pneumoniae. Infect Immun (2010) 0.93
Differential contribution of bacterial N-formyl-methionyl-leucyl- phenylalanine and host-derived CXC chemokines to neutrophil infiltration into pulmonary alveoli during murine pneumococcal pneumonia. Infect Immun (2007) 0.93
Acquisition of factor H by a novel surface protein on group B Streptococcus promotes complement degradation. FASEB J (2009) 0.93
Adhesion determinants of the Streptococcus species. Microb Biotechnol (2009) 0.90
Binding of human complement regulators FHL-1 and factor H to CRASP-1 orthologs of Borrelia burgdorferi. Wien Klin Wochenschr (2006) 0.89
Humoral innate immune response and disease. Clin Immunol (2012) 0.89
The lack of Pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglia. Med Microbiol Immunol (2005) 0.88
Adherence to streptococci facilitates Fusobacterium nucleatum integration into an oral microbial community. Microb Ecol (2011) 0.88
The pH-regulated antigen 1 of Candida albicans binds the human complement inhibitor C4b-binding protein and mediates fungal complement evasion. J Biol Chem (2011) 0.87
Pneumococcal PspA and PspC proteins: potential vaccine candidates for experimental otitis media. Int J Pediatr Otorhinolaryngol (2014) 0.83
Contribution of different pneumococcal virulence factors to experimental meningitis in mice. BMC Infect Dis (2013) 0.82
Bordetella pertussis acquires resistance to complement-mediated killing in vivo. Infect Immun (2003) 0.82
Purification and characterization of LPXTGase from Staphylococcus aureus: the amino acid composition mirrors that found in the peptidoglycan. J Bacteriol (2006) 0.81
Complement Evasion Mediated by Enhancement of Captured Factor H: Implications for Protection of Self-Surfaces from Complement. J Immunol (2015) 0.80
Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection. Clin Vaccine Immunol (2015) 0.80
Novel Evasion Mechanisms of the Classical Complement Pathway. J Immunol (2016) 0.80
Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials. Antibiotics (Basel) (2016) 0.79
Highly Variable Streptococcus oralis Strains Are Common among Viridans Streptococci Isolated from Primates. mSphere (2016) 0.79
Modified opsonization, phagocytosis, and killing assays to measure potentially protective antibodies against pneumococcal surface protein A. Clin Vaccine Immunol (2013) 0.78
Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC. Clin Vaccine Immunol (2012) 0.78
Targeted Proteomics and Absolute Protein Quantification for the Construction of a Stoichiometric Host-Pathogen Surface Density Model. Mol Cell Proteomics (2017) 0.78
Complement factor H in host defense and immune evasion. Cell Mol Life Sci (2016) 0.78
Interferon-γ from Brain Leukocytes Enhances Meningitis by Type 4 Streptococcus pneumoniae. Front Microbiol (2015) 0.77
Factor H Family Proteins in Complement Evasion of Microorganisms. Front Immunol (2017) 0.76
Early cytokine release in response to live Borrelia burgdorferi Sensu Lato Spirochetes is largely complement independent. PLoS One (2014) 0.76
Mapping of epitopes recognized by antibodies induced by immunization of mice with PspA and PspC. Clin Vaccine Immunol (2014) 0.76
Diverse evolutionary patterns of pneumococcal antigens identified by pangenome-wide immunological screening. Proc Natl Acad Sci U S A (2017) 0.76
Serotype 3 pneumococci sequester platelet-derived human thrombospondin-1 via the adhesin and immune evasion protein Hic. J Biol Chem (2017) 0.75
Genome-wide association study of IgG1 responses to the choline-binding protein PspC of Streptococcus pneumoniae. Genes Immun (2015) 0.75
A novel monoclonal antibody against FbaA can inhibit the binding of the complement regulatory protein factor H to group A streptococcus. Clin Vaccine Immunol (2011) 0.75
Impact of the glpQ2 gene on virulence in a Streptococcus pneumoniae serotype 19A sequence type 320 strain. Infect Immun (2014) 0.75
Role of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity. Front Microbiol (2017) 0.75
Competence for genetic transformation in encapsulated strains of Streptococcus pneumoniae: two allelic variants of the peptide pheromone. J Bacteriol (1996) 3.72
Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae. J Clin Microbiol (2002) 2.23
Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae. Antimicrob Agents Chemother (2000) 2.21
Insertional inactivation of the major autolysin gene of Streptococcus pneumoniae. J Bacteriol (1988) 2.18
Evolution of the mitochondrial genome of Metazoa as exemplified by comparison of congeneric species. Heredity (Edinb) (2008) 2.15
The type 2 capsule locus of Streptococcus pneumoniae. J Bacteriol (1999) 2.12
Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc Natl Acad Sci U S A (1995) 1.80
Surface display of recombinant proteins on Bacillus subtilis spores. J Bacteriol (2001) 1.79
Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat Biotechnol (2000) 1.79
Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci U S A (1998) 1.74
The tetracycline resistance gene tet(M) exhibits mosaic structure. Plasmid (1996) 1.51
Modes of integration of heterologous plasmid DNA into the chromosome of Streptococcus pneumoniae. J Bacteriol (1985) 1.48
Cloning and physical characterization of chromosomal conjugative elements in streptococci. J Bacteriol (1986) 1.47
Co-operative binding of human fibronectin to Sfbl protein triggers streptococcal invasion into respiratory epithelial cells. Cell Microbiol (2000) 1.36
A host-vector system for heterologous gene expression in Streptococcus gordonii. Gene (1996) 1.35
Object-orientated DBMS techniques for time-oriented medical record. Med Inform (Lond) (1993) 1.26
GeneSyn: a tool for detecting conserved gene order across genomes. Bioinformatics (2004) 1.23
Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J Clin Microbiol (1998) 1.20
Characterization of conjugative transposon Tn5251 of Streptococcus pneumoniae. FEMS Microbiol Lett (1996) 1.19
Managing different time granularities of clinical information by an interval-based temporal data model. Methods Inf Med (1995) 1.14
Electrotransformation of Streptococcus agalactiae with plasmid DNA. FEMS Microbiol Lett (1994) 1.14
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice. Vaccine (2001) 1.13
Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes. J Immunol (1999) 1.11
On the fate of ingested Bacillus spores. Res Microbiol (2000) 1.11
The joint of Tn916 circular intermediates is a homoduplex in Enterococcus faecalis. Plasmid (1997) 1.10
Expression of foreign proteins on gram-positive commensal bacteria for mucosal vaccine delivery. Curr Opin Biotechnol (1993) 1.08
Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis. Microb Drug Resist (1999) 1.08
Dosage of Tn916 circular intermediates in Enterococcus faecalis. Plasmid (1995) 1.06
Anhedonia and substance-related symptoms in detoxified substance-dependent subjects: a correlation study. Neuropsychobiology (2005) 1.06
Cellular retention, cytotoxicity and morphological transformation by vanadium(IV) and vanadium(V) in BALB/3T3 cell lines. Carcinogenesis (1991) 1.05
Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation. Carcinogenesis (1987) 1.04
Cellular retention, toxicity and carcinogenic potential of seafood arsenic. I. Lack of cytotoxicity and transforming activity of arsenobetaine in the BALB/3T3 cell line. Carcinogenesis (1991) 1.03
Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii. Infect Immun (2000) 1.00
Periodontal pathogens in atheromatous plaques. A controlled clinical and laboratory trial. J Periodontal Res (2004) 0.98
The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature. Int J Immunopathol Pharmacol (2010) 0.98
Immunization of mice by oral colonization with live recombinant commensal streptococci. Vaccine (1995) 0.97
Gram-positive commensal bacteria for mucosal vaccine delivery. Curr Opin Biotechnol (1996) 0.95
Engineering the gram-positive cell surface for construction of bacterial vaccine vectors. Methods (1999) 0.95
Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens. Vaccine (1998) 0.94
The puzzle of zmpB and extensive chain formation, autolysis defect and non-translocation of choline-binding proteins in Streptococcus pneumoniae. Mol Microbiol (2001) 0.93
Antigenicity and immunogenicity of the V3 domain of HIV type 1 glycoprotein 120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses (1999) 0.93
Conjugative transposon Tn916: evidence for excision with formation of 5'-protruding termini. J Bacteriol (1996) 0.92
Identification of Mycobacterium tuberculosis complex, Mycobacterium avium and Mycobacterium intracellulare by selective nested polymerase chain reaction. Mol Cell Probes (1995) 0.92
Transformation as a tool for studying the epidemiology of tet determinants in Streptococcus pneumoniae. Eur J Epidemiol (1986) 0.91
ARCADIA: a system for the integration of angiocardiographic data and images by an object-oriented DBMS. Comput Biomed Res (1995) 0.90
Direct sequencing of long polymerase chain reaction fragments. Mol Biotechnol (1998) 0.90
Complement activation, circulating C1q binding substances and inflammatory activity in rheumatoid arthritis: relations and changes on suppression of inflammation. J Clin Lab Immunol (1980) 0.89
Molecular detection of Leptospira interrogans in human tissues and environmental samples in a lethal case of leptospirosis. Int J Legal Med (2007) 0.89
Insertion vectors for construction of recombinant conjugative transposons in Bacillus subtilis and Enterococcus faecalis. FEMS Microbiol Lett (1998) 0.89
Nickel, cobalt and chromium-induced cytotoxicity and intracellular accumulation in human hacat keratinocytes. Toxicology (2001) 0.88
MS2/Cardio: towards a multi-service medical software for cardiology. Methods Inf Med (1992) 0.88
Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class II-restricted heterologous antigen expressed on recombinant Streptococcus gordonii. Infect Immun (2000) 0.87
Aripiprazole, alcohol and substance abuse: a review. Eur Rev Med Pharmacol Sci (2012) 0.87
The aggregation-promoting factor of Lactobacillus crispatus M247 and its genetic locus. J Appl Microbiol (2004) 0.87
Comparative genomics for identification of clone-specific sequence blocks in Streptococcus pneumoniae. FEMS Microbiol Lett (2001) 0.85
Vaginal immunization with recombinant gram-positive bacteria. Am J Reprod Immunol (1998) 0.84
Characterization of cryptic plasmids pDP1 and pSMB1 of Streptococcus pneumoniae. Plasmid (1999) 0.82
The intensity of vanadium(V)-induced cytotoxicity and morphological transformation in BALB/3T3 cells is dependent on glutathione-mediated bioreduction to vanadium(IV). Carcinogenesis (1993) 0.82
Immunoglobulin-binding domains of peptostreptococcal protein L enhance vaginal colonization of mice by Streptococcus gordonii. Microb Pathog (2001) 0.81
Characterization of JEOL 2100F Lorentz-TEM for low-magnification electron holography and magnetic imaging. Ultramicroscopy (2007) 0.81
The role of cholesterol levels in mood disorders and suicide. J Biol Regul Homeost Agents (2009) 0.81
Serendipitous rapid detoxification from opiates: the importance of time-dependent processes. Addiction (1999) 0.81
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial. J Psychopharmacol (2009) 0.80
High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients. Hum Psychopharmacol (2007) 0.80
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. Hum Psychopharmacol (2010) 0.79
Prolonged survival of heart allografts in rats treated with antisera to beta2-microglobulin. Transplantation (1977) 0.79
Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics. Int Clin Psychopharmacol (1996) 0.79
The role of IgM anti-HBc in the etiologic diagnosis of HBsAg-positive acute and chronic hepatitis. Ric Clin Lab (1984) 0.79
[Therapy of massive anastomotic hemorrhage after anterior mechanical rectocolonic resection]. G Chir (1991) 0.78
Conjugative mobilization of the cloned M6 protein gene from Streptococcus pneumoniae to Streptococcus pyogenes. Microbiologica (1990) 0.78
Mitochondrial DNA sequence variations in some Italian wild boar populations. J Anim Breed Genet (2009) 0.78
Recombinant Streptococcus gordonii for mucosal delivery of a scFv microbicidal antibody. Int Rev Immunol (2001) 0.78
Pharmacological approaches to the management of alcohol addiction. Eur Rev Med Pharmacol Sci (2003) 0.77
Biotechnological approaches to fight pathogens at mucosal sites. Biotechnol Genet Eng Rev (2001) 0.77
Increased reliability of selective PCR by using additionally mutated primers and a commercial Taq DNA polymerase enhancer. Mol Biotechnol (1995) 0.77
Bronchial hyperreactivity and arterial carboxyhemoglobin as detectors of air pollution in Milan: a study on normal subjects. Respiration (1985) 0.77
Control of B16 melanoma cells differentiation and proliferation by CuSO4 and vitamin C. Anticancer Res (1990) 0.77
Expression of measles virus antigens in Streptococcus gordonii. New Microbiol (2000) 0.76
Anti-idiotypic vaccination against group B streptococci. Int Rev Immunol (2001) 0.75
[Incidence of Streptococcus agalactiae in pregnant women in the 3d trimester of pregnancy]. Minerva Pediatr (1979) 0.75
Med-fly cell line: response to irradiations with fast neutrons and gamma-rays. Rev Can Biol Exp (1983) 0.75
Amiodarone lung toxicity: role of pulmonary function tests. Int J Clin Pharmacol Res (1987) 0.75
[Experimentation with 2-formyl-17(alpha)-methylandrosta-1,4-dien-11(alpha), 17(beta)-diol-3-one in geriatric clinic]. Clin Ter (1975) 0.75
[Studies on the risk factors of arteriosclerosis in a health district region of Lombardy]. Minerva Med (1976) 0.75
[The health check-up in industrial medicine]. Med Lav (1976) 0.75
[For specialized macro equipment]. Attual Dent (1987) 0.75
Congenital choledochal cysts: our experience. G Chir (1988) 0.75
[Experience in using josamycin in pediatrics]. G Ital Chemioter (1982) 0.75
Prevalence of Streptococcus mutans and dental decay in school children from Siena (Italy). Eur J Epidemiol (1989) 0.75
The influence of age on the recovery of the ERG photostress test. Doc Ophthalmol (2012) 0.75
[Radiological investigation of the small bowel by jejunal intubation with a directable device (author's transl)]. Radiol Med (1981) 0.75
[Findings on the knowledge of self-examination of the breast]. Tumori (1979) 0.75
[Use of transformation in the study of the homology of genes for drug resistance]. G Ital Chemioter (1986) 0.75
Prevalence of human papillomaviruses in cervical scrapings of unselected women. Eur J Clin Microbiol Infect Dis (1990) 0.75
Effects of FeSO4 on B16 melanoma cells differentiation and proliferation. Anticancer Res (1990) 0.75
A drug-to-drug interaction package. Comput Methods Programs Biomed (1989) 0.75